Sagimet Biosciences Inc. (SGMT) — Analyst outlook / Analyst consensus target is. Based on 6 analyst ratings, the consensus is bullish — 5 Buy, 1 Hold.
The consensus price target is $8.00, representing an upside of 44.4% from the current price $5.54.
Analysts estimate Earnings Per Share (EPS) of $-1.57 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.45 vs est $-1.57 (beat +7.5%). 2025: actual $-1.58 vs est $-1.66 (beat +5.1%). Analyst accuracy: 93%.
SGMT Stock — 12-Month Price Forecast
$8.00
▲ +44.40% Upside
Average Price Target
Based on 6 Wall Street analysts offering 12-month price targets for Sagimet Biosciences Inc., the price target is $8.00.
The average price target represents a +44.40% change from the last price of $5.54.
SGMT Analyst Ratings
Buy
Based on 6 analysts giving stock ratings to Sagimet Biosciences Inc. in the past 3 months
EPS Estimates — SGMT
93%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$1.45
vs Est –$1.57
▲ 8.1% off
2025
Actual –$1.58
vs Est –$1.66
▲ 5.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — SGMT
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
